midazolam has been researched along with Attention Deficit Disorder with Hyperactivity in 5 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The primary objective of the current study was to assess differences in blood pressure and heart rate before and after induction of anesthesia between patients on chronic amphetamine or methylphenidate therapy who receive their normal dose preoperatively compared to patients in whom the prescribed medication was withheld." | 3.85 | Hemodynamic profile and behavioral characteristics during induction of anesthesia in pediatric patients with attention deficit hyperactivity disorder. ( Cartabuke, RS; Rice, J; Tobias, JD; Tumin, D, 2017) |
| "We report difficulty with conscious sedation of a child taking methylphenidate for attention deficit disorder and possible delayed adverse interaction of ketamine and methylphenidate resulting in severe nausea, vomiting and dehydration." | 3.69 | Unexpected interaction of methylphenidate (Ritalin) with anaesthetic agents. ( Fox, L; Ririe, DG; Ririe, KL; Sethna, NF, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cartabuke, RS | 1 |
| Tobias, JD | 1 |
| Rice, J | 1 |
| Tumin, D | 1 |
| Schmerler, BL | 1 |
| Cohen, DM | 1 |
| Leder, MS | 1 |
| Bonsu, BK | 1 |
| Al-Alami, AA | 1 |
| Tesoro, S | 1 |
| Vicchio, N | 1 |
| Marchesini, L | 1 |
| Aldo Peduto, V | 1 |
| Ririe, DG | 1 |
| Ririe, KL | 1 |
| Sethna, NF | 1 |
| Fox, L | 1 |
1 trial available for midazolam and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Sedation of children with ADHD: trazodone or midazolam?
Topics: Anti-Anxiety Agents; Attention Deficit Disorder with Hyperactivity; Child; Conscious Sedation; Human | 2007 |
4 other studies available for midazolam and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Hemodynamic profile and behavioral characteristics during induction of anesthesia in pediatric patients with attention deficit hyperactivity disorder.
Topics: Adolescent; Amphetamine; Anesthesia; Anti-Anxiety Agents; Anxiety; Attention Deficit Disorder with H | 2017 |
Procedural sedation for fracture reduction in children with hyperactivity.
Topics: Adjuvants, Anesthesia; Adolescent; Attention Deficit Disorder with Hyperactivity; Case-Control Studi | 2008 |
Successful treatment of early ropivacaine toxicity with intralipid in a patient with attention deficit hyperactivity disorder.
Topics: Adolescent; Amides; Anesthesia, General; Anesthetics, Local; Arthroscopy; Atomoxetine Hydrochloride; | 2011 |
Unexpected interaction of methylphenidate (Ritalin) with anaesthetic agents.
Topics: Anesthetics, Dissociative; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti | 1997 |